Assessment of azole resistance in clinical settings by passive sampling

Liliana Aranha Caetano, Beatriz Almeida, Carla Viegas

Research output: Chapter in Book/Report/Conference proceedingConference contribution

Abstract

The exposure to fungal burden is an increased risk factor for the development of respiratory symptoms and fungal diseases. The emergence worldwide of azole resistance in fungal species is a major concern for public health. Clinical settings must provide a clean and safe environment to protect patients and staff from fungal diseases. The aim of this study was to assess the fungal burden and prevalence of azole resistance in clinical settings in Portugal using passive sampling methods. Ten Primary Health Care Centers were evaluated through passive sampling, including electrostatic dust cloths, heating ventilation and air conditioning filters, and settled dust. All samples were plated onto Sabouraud dextrose agar media and screened for azole resistance using agar media supplemented with itraconazole, voriconazole and posaconazole through incubation at 27 °C, for 5 days. Fungal species were identified based on macro and micromorphology. Fungal load ranged from 348 to 424628 CFU·m−2 in EDC, 0 to 56500 CFU·m−2 in HVAC filter, and 2 to 514 CFU·g−1 in settled dust. EDC samples presented the highest fungal loads and wider diversity. Azole resistance was observed in all Primary Health Care Centers. Multi-azole resistance (fungal growth in two or more azoles) was observed in 90% units for Penicillium sp., C. sitophila, and Cladosporium sp. None of the samples containing Aspergillus sp. colonies presented resistance to the tested azoles. The knowledge of the fungal burden and prevalence of resistance to azole-based antifungal drugs in clinical environments will allow a better risk characterization regarding fungal burden.

Original languageEnglish
Title of host publicationHealth and social care systems of the future
Subtitle of host publicationdemographic changes, digital age and human factors: proceedings of the Healthcare Ergonomics and Patient Safety, HEPS 2019
EditorsTeresa Patrone Cotrim, Florentino Serranheira, Paulo Sousa, Sue Hignett, Sara Albolino, Riccardo Tartaglia
PublisherSpringer Verlag
Pages248-256
Number of pages9
ISBN (Print)9783030240660
DOIs
Publication statusPublished - 1 Jan 2019
EventInternational Conference on Healthcare Ergonomics and Patient Safety, HEPS 2019 - Lisbon, Portugal
Duration: 3 Jul 20195 Jul 2019

Publication series

NameAdvances in Intelligent Systems and Computing
Volume1012
ISSN (Print)2194-5357

Conference

ConferenceInternational Conference on Healthcare Ergonomics and Patient Safety, HEPS 2019
CountryPortugal
CityLisbon
Period3/07/195/07/19

Fingerprint

Dust
Sampling
Health care
Dextrose
Aspergillus
Public health
Air conditioning
Ventilation
Macros
Electrostatics
Heating
HVAC

Keywords

  • Azole resistance
  • Clinical environment
  • Passive sampling

Cite this

Caetano, L. A., Almeida, B., & Viegas, C. (2019). Assessment of azole resistance in clinical settings by passive sampling. In T. P. Cotrim, F. Serranheira, P. Sousa, S. Hignett, S. Albolino, & R. Tartaglia (Eds.), Health and social care systems of the future: demographic changes, digital age and human factors: proceedings of the Healthcare Ergonomics and Patient Safety, HEPS 2019 (pp. 248-256). (Advances in Intelligent Systems and Computing; Vol. 1012). Springer Verlag. https://doi.org/10.1007/978-3-030-24067-7_29
Caetano, Liliana Aranha ; Almeida, Beatriz ; Viegas, Carla. / Assessment of azole resistance in clinical settings by passive sampling. Health and social care systems of the future: demographic changes, digital age and human factors: proceedings of the Healthcare Ergonomics and Patient Safety, HEPS 2019. editor / Teresa Patrone Cotrim ; Florentino Serranheira ; Paulo Sousa ; Sue Hignett ; Sara Albolino ; Riccardo Tartaglia. Springer Verlag, 2019. pp. 248-256 (Advances in Intelligent Systems and Computing).
@inproceedings{3363e06cc79c4316994169073b321b61,
title = "Assessment of azole resistance in clinical settings by passive sampling",
abstract = "The exposure to fungal burden is an increased risk factor for the development of respiratory symptoms and fungal diseases. The emergence worldwide of azole resistance in fungal species is a major concern for public health. Clinical settings must provide a clean and safe environment to protect patients and staff from fungal diseases. The aim of this study was to assess the fungal burden and prevalence of azole resistance in clinical settings in Portugal using passive sampling methods. Ten Primary Health Care Centers were evaluated through passive sampling, including electrostatic dust cloths, heating ventilation and air conditioning filters, and settled dust. All samples were plated onto Sabouraud dextrose agar media and screened for azole resistance using agar media supplemented with itraconazole, voriconazole and posaconazole through incubation at 27 °C, for 5 days. Fungal species were identified based on macro and micromorphology. Fungal load ranged from 348 to 424628 CFU·m−2 in EDC, 0 to 56500 CFU·m−2 in HVAC filter, and 2 to 514 CFU·g−1 in settled dust. EDC samples presented the highest fungal loads and wider diversity. Azole resistance was observed in all Primary Health Care Centers. Multi-azole resistance (fungal growth in two or more azoles) was observed in 90{\%} units for Penicillium sp., C. sitophila, and Cladosporium sp. None of the samples containing Aspergillus sp. colonies presented resistance to the tested azoles. The knowledge of the fungal burden and prevalence of resistance to azole-based antifungal drugs in clinical environments will allow a better risk characterization regarding fungal burden.",
keywords = "Azole resistance, Clinical environment, Passive sampling",
author = "Caetano, {Liliana Aranha} and Beatriz Almeida and Carla Viegas",
year = "2019",
month = "1",
day = "1",
doi = "10.1007/978-3-030-24067-7_29",
language = "English",
isbn = "9783030240660",
series = "Advances in Intelligent Systems and Computing",
publisher = "Springer Verlag",
pages = "248--256",
editor = "Cotrim, {Teresa Patrone} and Florentino Serranheira and Paulo Sousa and Sue Hignett and Sara Albolino and Riccardo Tartaglia",
booktitle = "Health and social care systems of the future",
address = "Germany",

}

Caetano, LA, Almeida, B & Viegas, C 2019, Assessment of azole resistance in clinical settings by passive sampling. in TP Cotrim, F Serranheira, P Sousa, S Hignett, S Albolino & R Tartaglia (eds), Health and social care systems of the future: demographic changes, digital age and human factors: proceedings of the Healthcare Ergonomics and Patient Safety, HEPS 2019. Advances in Intelligent Systems and Computing, vol. 1012, Springer Verlag, pp. 248-256, International Conference on Healthcare Ergonomics and Patient Safety, HEPS 2019, Lisbon, Portugal, 3/07/19. https://doi.org/10.1007/978-3-030-24067-7_29

Assessment of azole resistance in clinical settings by passive sampling. / Caetano, Liliana Aranha; Almeida, Beatriz; Viegas, Carla.

Health and social care systems of the future: demographic changes, digital age and human factors: proceedings of the Healthcare Ergonomics and Patient Safety, HEPS 2019. ed. / Teresa Patrone Cotrim; Florentino Serranheira; Paulo Sousa; Sue Hignett; Sara Albolino; Riccardo Tartaglia. Springer Verlag, 2019. p. 248-256 (Advances in Intelligent Systems and Computing; Vol. 1012).

Research output: Chapter in Book/Report/Conference proceedingConference contribution

TY - GEN

T1 - Assessment of azole resistance in clinical settings by passive sampling

AU - Caetano, Liliana Aranha

AU - Almeida, Beatriz

AU - Viegas, Carla

PY - 2019/1/1

Y1 - 2019/1/1

N2 - The exposure to fungal burden is an increased risk factor for the development of respiratory symptoms and fungal diseases. The emergence worldwide of azole resistance in fungal species is a major concern for public health. Clinical settings must provide a clean and safe environment to protect patients and staff from fungal diseases. The aim of this study was to assess the fungal burden and prevalence of azole resistance in clinical settings in Portugal using passive sampling methods. Ten Primary Health Care Centers were evaluated through passive sampling, including electrostatic dust cloths, heating ventilation and air conditioning filters, and settled dust. All samples were plated onto Sabouraud dextrose agar media and screened for azole resistance using agar media supplemented with itraconazole, voriconazole and posaconazole through incubation at 27 °C, for 5 days. Fungal species were identified based on macro and micromorphology. Fungal load ranged from 348 to 424628 CFU·m−2 in EDC, 0 to 56500 CFU·m−2 in HVAC filter, and 2 to 514 CFU·g−1 in settled dust. EDC samples presented the highest fungal loads and wider diversity. Azole resistance was observed in all Primary Health Care Centers. Multi-azole resistance (fungal growth in two or more azoles) was observed in 90% units for Penicillium sp., C. sitophila, and Cladosporium sp. None of the samples containing Aspergillus sp. colonies presented resistance to the tested azoles. The knowledge of the fungal burden and prevalence of resistance to azole-based antifungal drugs in clinical environments will allow a better risk characterization regarding fungal burden.

AB - The exposure to fungal burden is an increased risk factor for the development of respiratory symptoms and fungal diseases. The emergence worldwide of azole resistance in fungal species is a major concern for public health. Clinical settings must provide a clean and safe environment to protect patients and staff from fungal diseases. The aim of this study was to assess the fungal burden and prevalence of azole resistance in clinical settings in Portugal using passive sampling methods. Ten Primary Health Care Centers were evaluated through passive sampling, including electrostatic dust cloths, heating ventilation and air conditioning filters, and settled dust. All samples were plated onto Sabouraud dextrose agar media and screened for azole resistance using agar media supplemented with itraconazole, voriconazole and posaconazole through incubation at 27 °C, for 5 days. Fungal species were identified based on macro and micromorphology. Fungal load ranged from 348 to 424628 CFU·m−2 in EDC, 0 to 56500 CFU·m−2 in HVAC filter, and 2 to 514 CFU·g−1 in settled dust. EDC samples presented the highest fungal loads and wider diversity. Azole resistance was observed in all Primary Health Care Centers. Multi-azole resistance (fungal growth in two or more azoles) was observed in 90% units for Penicillium sp., C. sitophila, and Cladosporium sp. None of the samples containing Aspergillus sp. colonies presented resistance to the tested azoles. The knowledge of the fungal burden and prevalence of resistance to azole-based antifungal drugs in clinical environments will allow a better risk characterization regarding fungal burden.

KW - Azole resistance

KW - Clinical environment

KW - Passive sampling

UR - http://www.scopus.com/inward/record.url?scp=85068600679&partnerID=8YFLogxK

U2 - 10.1007/978-3-030-24067-7_29

DO - 10.1007/978-3-030-24067-7_29

M3 - Conference contribution

SN - 9783030240660

T3 - Advances in Intelligent Systems and Computing

SP - 248

EP - 256

BT - Health and social care systems of the future

A2 - Cotrim, Teresa Patrone

A2 - Serranheira, Florentino

A2 - Sousa, Paulo

A2 - Hignett, Sue

A2 - Albolino, Sara

A2 - Tartaglia, Riccardo

PB - Springer Verlag

ER -

Caetano LA, Almeida B, Viegas C. Assessment of azole resistance in clinical settings by passive sampling. In Cotrim TP, Serranheira F, Sousa P, Hignett S, Albolino S, Tartaglia R, editors, Health and social care systems of the future: demographic changes, digital age and human factors: proceedings of the Healthcare Ergonomics and Patient Safety, HEPS 2019. Springer Verlag. 2019. p. 248-256. (Advances in Intelligent Systems and Computing). https://doi.org/10.1007/978-3-030-24067-7_29